|
業務類別
|
-- |
|
業務概覽
|
Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment. |
| 公司地址
| 1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109 |
| 電話號碼
| +61 294286555 |
| 傳真號碼
| +61 294286353 |
| 公司網頁
| https://www.cochlear.com |
| 員工數量
| 5500 |
| Mr. Dig Howitt |
Chief Executive Officer, President, Managing Director and Director |
-- |
14/08/2025 |
|
|
| Mr. Michael del Prado |
Independent Director |
14/08/2025 |
| Ms. Christine McLoughlin, A.M. |
Independent Director |
14/08/2025 |
| Mr. Glen Boreham, A.M. |
Independent Director |
14/08/2025 |
| Mr. Dig Howitt |
Chief Executive Officer, President, Managing Director and Director |
14/08/2025 |
| Ms. Karen Penrose |
Independent Director |
14/08/2025 |
| Professor Bruce Robinson, A.C.,F.R.A.C.P.,M.D. |
Independent Director |
14/08/2025 |
| Sir Michael Daniell |
Independent Director |
14/08/2025 |
| Ms. Alison Deans, M.A.,M.B.A. |
Chairman of the Board |
14/08/2025 |
| Ms. Caroline Clarke |
Director |
14/08/2025 |
|
|
|
|
